An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence
Quiescence must be actively maintained in cells of the immune response. Beutler and colleagues describe a new mutant mouse, elektra, with defective control of T cell and monocyte quiescence; this defect maps to Slfn2 . Here we describe a previously unknown form of inherited immunodeficiency revealed...
Saved in:
Published in | Nature immunology Vol. 11; no. 4; pp. 335 - 343 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.04.2010
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Quiescence must be actively maintained in cells of the immune response. Beutler and colleagues describe a new mutant mouse, elektra, with defective control of T cell and monocyte quiescence; this defect maps to
Slfn2
.
Here we describe a previously unknown form of inherited immunodeficiency revealed by an
N
-ethyl-
N
-nitrosourea–induced mutation called
elektra
. Mice homozygous for this mutation showed enhanced susceptibility to bacterial and viral infection and diminished numbers of T cells and inflammatory monocytes that failed to proliferate after infection and died via the intrinsic apoptotic pathway in response to diverse proliferative stimuli. They also had a greater proportion of T cells poised to replicate DNA, and their T cells expressed a subset of activation markers, suggestive of a semi-activated state. We positionally ascribe the elektra phenotype to a mutation in the gene encoding Schlafen-2 (
Slfn2
). Our findings identify a physiological role for Slfn2 in the defense against pathogens through the regulation of quiescence in T cells and monocytes. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 Current address: Centre d’Immunologie de Marseille-Luminy, Marseille, France Current address: Cancer and Haematology Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia Author contributions M.B. and B.B. designed the research with critical suggestions from P.K., K.C., and A.N.T.; M.B., P.K., K.C., X.L., B.A.C., O.M.S., D.P., and B.R.L. performed experiments; X.L. and X.D. generated the BAC transgenic mice. M.B., Y.X. and K.K. performed all genome mapping. T.S., O.T., and S.A. generated Slfn3-/- and Slfn1-/- mice. M.B., E.M.Y.M., and B.B. wrote the manuscript. |
ISSN: | 1529-2908 1529-2916 |
DOI: | 10.1038/ni.1847 |